While there may be some benefits, we dont have enough studies at this time to fully support the use. As a board-certified dermatologist, my goal is to recommend treatments that have demonstrated both safety and efficacy, and patients should be cautious of products making anti-aging claims without robust clinical data or appropriate regulatory oversight. Verbois adds that when a product is injected, there is very little margin for error
The improved regulation of glycemia by GLP-1RA, along with their ability to reduce lipid synthesis, enhanced beta oxidation of free fatty acids and autophagy of fat cells contributes to their lipid modulation properties (59)
Dixon, B
For a 5 mg vial, 2 mL of bacteriostatic water creates a 2.5 mg/mL solution
Color development was performed using DAB working solution for 10 min at room temperature and terminated by rinsing with ddHO
This section will briefly review what we know about the current safety data of GLP-1 and GLP-1/GIP agonists, and factors that may promote long term clinical use of these agents in obesity
